Loading...
XSHE002612
Market cap887mUSD
Jan 13, Last price  
14.70CNY
1D
-0.27%
1Q
-0.68%
Jan 2017
-11.15%
IPO
-22.01%
Name

Lancy Co Ltd

Chart & Performance

D1W1MN
XSHE:002612 chart
P/E
28.90
P/S
1.26
EPS
0.51
Div Yield, %
0.00%
Shrs. gr., 5y
2.04%
Rev. gr., 5y
14.09%
Revenues
5.15b
+32.67%
222,617,619308,998,527559,146,168836,233,0781,117,494,6811,378,831,1971,235,436,7571,144,252,8131,367,738,3302,353,265,9512,661,549,9023,007,255,1552,876,436,7293,665,214,5663,878,277,8245,145,464,417
Net income
225m
+549.49%
37,645,24962,381,375123,287,041208,660,759231,290,677233,737,256121,224,94074,456,433164,015,756187,571,319210,453,08940,725,009142,036,818173,453,58334,655,348225,081,500
CFO
842m
+257.20%
41,092,79061,813,159157,206,87564,667,8753,305,20812,912,62635,511,480150,825,033132,432,455129,370,75054,383,382596,746,640379,278,066470,584,897235,666,570841,810,542
Dividend
May 31, 20240.45 CNY/sh
Earnings
May 15, 2025

Profile

Lancy Co., Ltd. engages in the design, production, and sale of branded women's clothing. The company offers women's wear under the LANCYFROM25, LIMEFLARE, liaalancy, MOJOS.PHINE, JIGOTT, FABIANAFILIPPI, and m.tsubomi brand names. It is also involved in the medical and cosmetic business, which include management and operation of medical institutions under the Milan Boyu brand; laser and micro-shaping medical cosmetic services under the medical youth brand name; and operation of medical and aesthetic centers, which offer cosmetic surgery, cosmetic dermatology, cosmetic Chinese medicine, cosmetic dentistry, and micro-plastic surgery under the Gaoyisheng Medical Beauty brand. The company also provides infants and children's clothing under the Agabang, ETTOI, Putto, Designskin, and DearBaby brand names. It markets its products through stores, as well as online. The company was founded in 2000 and is based in Beijing, China.
URL
http://www.lancygroup.com
IPO date
Aug 30, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,145,464
32.67%
3,878,278
5.81%
Cost of revenue
3,532,654
3,514,082
Unusual Expense (Income)
NOPBT
1,612,810
364,195
NOPBT Margin
31.34%
9.39%
Operating Taxes
39,131
7,947
Tax Rate
2.43%
2.18%
NOPAT
1,573,679
356,249
Net income
225,082
549.49%
34,655
-80.02%
Dividends
(30,971)
Dividend yield
0.25%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
683,744
928,907
Long-term debt
1,681,110
1,801,294
Deferred revenue
3,571
4,831
Other long-term liabilities
118,215
1
Net debt
(68,832)
612,426
Cash flow
Cash from operating activities
841,811
235,667
CAPEX
(112,084)
Cash from investing activities
(430,858)
Cash from financing activities
(420,550)
FCF
1,803,207
79,735
Balance
Cash
489,536
436,114
Long term investments
1,944,151
1,681,661
Excess cash
2,176,414
1,923,861
Stockholders' equity
2,136,011
2,078,422
Invested Capital
3,275,044
3,698,686
ROIC
45.13%
10.17%
ROCE
29.34%
6.38%
EV
Common stock shares outstanding
442,445
442,445
Price
19.23
-30.73%
27.76
-12.22%
Market cap
8,508,225
-30.73%
12,282,284
-12.22%
EV
9,170,275
13,634,229
EBITDA
1,896,156
550,369
EV/EBITDA
4.84
24.77
Interest
95,115
85,879
Interest/NOPBT
5.90%
23.58%